A diagnosis of SSc may confer an increased risk of death 1 year following lung transplantation compared to a diagnosis of ILD, but this risk is similar to that of PAH, a widely accepted indication for lung transplantation. PubMed, Arthritis Rheumatol, 01/07/2015. (Also see: Lung Transplants)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.